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TOR signaling regulates microtubule structure and function
Jae H. Choi*, Neil R. Adames†, Ting-Fung Chan*, Chenbo Zeng*,
John A. Cooper† and X.F. Steven Zheng*
The functional diversity and structural heterogeneity
of microtubules are largely determined by microtubule-
associated proteins (MAPs) [1,2]. Bik1p (bilateral
karyogamy defect protein) is one of the MAPs required
for microtubule assembly, stability and function in cell
processes such as karyogamy and nuclear migration
and positioning in the yeast Saccharomyces cerevisiae
[3]. The macrocyclic immunosuppressive antibiotic
rapamycin, complexed with its binding protein FKBP12,
binds to and inhibits the target of rapamycin protein
(TOR) in yeast [4,5]. We report here that TOR physically
interacts with Bik1p, the yeast homolog of human
CLIP-170/Restin [6,7]. Inhibition of TOR by rapamycin
significantly affects microtubule assembly, elongation
and stability. This function of TOR is independent of
new protein synthesis. Rapamycin also causes defects
in spindle orientation, nuclear movement and
positioning, karyogamy and chromosomal stability,
defects also found in the bikD mutant. Our data suggest
a role for TOR signaling in regulating microtubule
stability and function, possibly through Bik1p.
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Results and discussion
On screening yeast mutants we found that cin8D con-
ferred hypersensitivity to rapamycin (Figure 1a). Cin8p is
one of six kinesin-related proteins (KRPs) and has a major
role in spindle pole separation and anaphase spindle elon-
gation [8,9]. This prompted us to examine rapamycin sen-
sitivity in five other KRP mutants (kip1D, kip2D, kip3D,
kar3D and smy1D). As cin8D is synthetically lethal with
mutant alleles of PAC genes (perish in the absence of
CIN8) [10], we also examined seven pac mutants for
rapamycin sensitivity. We found that kip2D, pac3D/jnm1D,
pac10D, pac12D/num1D, pac13D/nip100D and pac14D/bik1D
displayed varying degrees of sensitivity to rapamycin.
The pac14D strains were most sensitive (Figure 1b). The
five Pac proteins are involved in microtubule or dynein-
like functions [8,9]. Pac14p, also known as Bik1p [11], is
required for microtubule stability and function during
mitosis and mating [3]. These results suggest that
rapamycin-sensitive signaling is involved in microtubule
stability and function.
Figure 1
The rapamycin sensitivity of yeast mutants defective in kinesin-related
proteins (KRPs) and interaction between Tor1p and Bik1p. (a,b) The
rapamycin sensitivity of cin8D, kip2D and bik1D/pac14D mutant
strains. The isogenic haploid strains indicated were grown in YPD
medium with (right panels) and without (left panels) 10 nM rapamycin.
Each spot represents a tenfold dilution of the culture. (c) Tor1p
interacts with Bik1p in vivo. The left panel shows binding of
Tor1p–Myc9 to Bik1p–ProA5. Lysates of yeast cells expressing
Tor1p–Myc9 and Bik1p–ProA5 or Bik1p were purified on
IgG–Sepharose beads, and analyzed by western blotting. The right
panel shows binding of Bik1p–Myc9 to Tor1p–ProA5. T, total lysate;
IP, the IgG–Sepharose-bound materials. The sample in each T lane
represents 10% of that in the corresponding IP lane.
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Bik1p/Pac14p strongly interacts with full-length Tor1p in a
yeast two-hybrid screen (Figure 1c). To confirm their
interaction in vivo, we generated nine-repeat Myc (Myc9)
and five-repeat Protein A (ProA5) epitope tags on the chro-
mosomal copies of TOR1 and BIK1 in different combina-
tions. We found that a substantial portion of Tor1p–Myc9
was specifically co-precipitated in the presence of
Bik1p–ProA5, but not with Bik1p on IgG–sepharose beads
(Figure 1d). Conversely, Bik1p–Myc9 was co-precipitated
with Tor1p–ProA5 but not with Tor1p (Figure 1d). There-
fore, Tor1p and Bik1p interact well with each other at their
physiological concentrations. We also found that Tor2p
interacted with Bik1p in a yeast two-hybrid assay (data not
shown), suggesting that Tor1p and Tor2p share the Bik1p-
related function(s).
To investigate a role for TOR in Bik1p-related functions
such as microtubule stability, we analyzed the effect of
rapamycin on microtubule structure. Rapamycin treat-
ment caused several morphological abnormalities
(Figure 2a). Cytoplasmic microtubule structures rapidly
disappeared in the presence of rapamycin, and were barely
detectable by 20 minutes of rapamycin treatment. Pre-
anaphase spindles became much thinner and shorter. In
contrast, FK506, a rapamycin structural analog that does
not inhibit TOR, did not have any discernible effect on
microtubules (Figure 2a). Rapamycin had no effect on
microtubules in cells harboring a plasmid-based dominant
rapamycin-resistant TOR1 (pTOR1S1972I) [12] (Figure 2a).
Therefore, the microtubule structural defects are caused
by inhibition of TOR by rapamycin.
Both BIK1 and ASE1 are essential for anaphase spindle
elongation [13]. To investigate the effects of rapamycin on
spindle elongation in live cells, we measured, by time-
lapse movies, the kinetics of both fast and slow phases of
spindle elongation in cells expressing a fusion of tubulin
and green fluorescent protein (GFP). We found that both
phases of spindle elongation were significantly slower
(p < 0.05) in the rapamycin-treated cells (Figure 2b). In
addition, the pre-anaphase (p < 0.05) and anaphase spin-
dles (p < 0.001) in the rapamycin-treated cells were signifi-
cantly shorter than those in the untreated cells (Figure 2b).
The timing of cell-cycle events in the rapamycin-treated
cells was not significantly affected  (data not shown).
Therefore, rapamycin inhibits the kinetics of spindle elon-
gation. To determine whether rapamycin affects the exist-
ing spindle, we examined the stability of preformed
spindles in cdc2, cdc13 and cdc15 temperature-sensitive (ts)
mutants [14–16]. At the non-permissive temperature
(36°C), these strains arrest at S, G2 and M phases of the
cell cycle, respectively. The arrested cells showed stable,
normal spindle structures (Figure 2c). Rapamycin, but not
FK506 (up to 2 mM), caused morphological abnormalities
in the spindles (Figure 2c). As rapamycin inhibits transla-
tion, we treated the arrested mutant cells with cyclohex-
imide to see whether new protein synthesis is required for
maintaining the spindle structures. The microtubule struc-
tures remained intact in the cycloheximide-treated cells
under the same conditions (Figure 2c), indicating that this
function of TOR is independent of new protein synthesis.
Thus, TOR is required for maintaining spindle structures
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Figure 2
Rapamycin causes defects in microtubule stability, spindle elongation
and spindle position. (a) Morphological abnormalities after rapamycin
treatment. Log-phase cells carrying a wild-type (pTOR1WT) or
dominant rapamycin-resistant TOR1 (pTOR1S1972I) were treated
without any drug (control), or with 100 nM rapamycin or FK506 at
30°C for 20 min. In (a,c) the panels labeled DAPI have been stained to
show the nucleus; the panels labeled TUB have been stained with anti-
tubulin antibody to show microtubules. (b) Reduction of pre-anaphase
spindle length and anaphase spindle elongation kinetics by rapamycin.
(c) Rapamycin destabilizes the existing spindles. The cdc2, cdc13 and
cdc15 ts mutants were arrested at S, G2 and M, respectively, at 36°C
for 3 h. The arrested cells were then treated with 200 nM rapamycin,
200 nM FK506, or 50 mg/ml cycloheximide (+ CHX). (d) Western
analysis of in vitro polymerized microtubules. Rapamycin interferes with
microtubule polymerization. High-speed extracts from yeast cells
treated without (lane 1) or with 200 nM rapamycin for 20 min (lane 2)
were incubated without or with GTP and taxol (lanes 3–6). The results
were analyzed by western blotting with an anti-tubulin antibody.
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and this function appears to be distinct from its roles in the
control of transcription and translation [4,5]. 
We addressed the question of whether TOR is involved in
the assembly of microtubules by using an in vitro assay for
microtubule polymerization induced by GTP and taxol
[17,18]. We prepared high-speed extracts from yeast cells
treated with or without rapamycin. The extracts contained
a large amount of tubulin monomers, and rapamycin treat-
ment did not affect the abundance of tubulin monomers
in the supernatant (Figure 2d). GTP and taxol induced
polymerization of tubulin into microtubules, as indicated
by the sedimentation centrifugation assay (Figure 2d).
The result showed that the ability of tubulin monomers to
form microtubules from the rapamycin-treated extracts
was significantly reduced (Figure 2d). Thus, TOR appears
to be involved in microtubule assembly.
We also found a high incidence of binucleate cells after
treatment with rapamycin (Figure 3a). Three additional
aberrant phenotypes were obvious in rapamycin: in the
first, nuclei were positioned away from the neck between
mother cell and bud; the second showed internal mitosis
(in which the elongated anaphase nucleus remained in the
mother); and the third showed internal mitosis with incor-
rect spindle orientation (Figure 3b). As the binucleate
phenotype can be due to failure of either nuclear migration
to the neck or spindle penetration into the neck [19],
we measured nuclear position in cells released from
pheromone arrest into medium with or without rapamycin.
Control cells correctly positioned their nuclei next to the
bud neck, whereas the positions of nuclei in the
rapamycin-treated cells were much more random and their
nuclear migration index was significantly higher, behavior
similar to that in bik1D cells without rapamycin (Figure 3c).
Therefore, the binucleate phenotype in the rapamycin-
treated cells is at least partly due to failure of the nucleus
to migrate to the mother–bud neck before the onset of
anaphase B. Rapamycin did not, however, exacerbate the
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Figure 3
Rapamycin treatment causes defects in nuclear migration, spindle
orientation and spindle position. (a,b) Rapamycin causes defects in
nuclear segregation and position. Rapamycin (2 nM) was added to the
early exponential wild-type yeast culture and incubated for two
generations. In (a) bright-field images were overlain with DAPI images
to show the positions of nuclear DNA. Binucleate cells, indicating
abnormal segregation, are indicated by arrows. The percentages of
cells with aberrant nuclear position are given in (b). For each strain, the
table shows the total cells counted (n), the percentages of cells at the
different bud sizes, and the percentages of cells with the specified
abnormalities relative to total cells counted. (c) Rapamycin affects
nuclear migration to the neck. Cells were arrested with a factor,
released into fresh media with or without 2 nM rapamycin for 30 min,
fixed, and stained with DAPI. The distance between the neck and the
nearest edge of DAPI staining was measured and divided by the
distance between the neck and the distal edge of the mother cortex to
derive the nucleus migration index. The scale along the bottom of the
histograms is in increments of 0.1. (d) Analysis of spindle orientations
in wild-type cells expressing GFP–tubulin, with and without rapamycin.
All measurements were done on pre-anaphase spindles at 1 min
before onset of anaphase B. (e) Analysis of spindle positions in wild-
type cells expressing GFP–tubulin, with or without rapamycin.
defects in the bik1D cells (Figure 3b,c), suggesting that the
rapamycin effect is mediated by Bik1p. There was a mod-
erate, but clearly detectable, increase in multinucleate
tor1D cells in the absence of rapamycin, further indicating
that TOR is directly involved in the microtubule-related
processes. The relatively small defect associated with the
tor1D mutation is likely to be due to redundancy between
Tor1p and Tor2p.
We also examined the effect of rapamycin on pre-
anaphase spindle orientation relative to the mother–bud
axis and on spindle positions relative to the bud neck, at
1 minute before the onset of anaphase in live cells
expressing GFP–tubulin. Spindle orientation in
rapamycin-treated cells was significantly more random
(p < 0.05) than in control cells. Moreover, a significant pro-
portion (22.2%) of the rapamycin-treated cells had spin-
dles oriented > 60 degrees from the mother–bud axis
(Figure 3d). The distance of the spindle from the neck
also significantly increased (p < 0.001) in rapamycin-
treated cells (Figure 3e). These results indicate that the
nuclear positioning defects we observed are the result of
aberrant pre-anaphase spindle orientation and positioning.
Our results reveal a new role for TOR signaling in the reg-
ulation of microtubule structure and function, which
appears to be mediated by Bik1p. Rapamycin affects chro-
mosomal stability in both mammalian cells and yeast ([20],
and see Supplementary material), suggesting that the
microtubule-related function of TOR is conserved.
How does TOR regulate the activity of Bik1p? Phospho-
rylation of CLIP-170 has been implicated in determining
the assembly, orientation and stability of microtubules
[24]. As TOR is a protein kinase [21–23], it may directly
phosphorylate, or regulate the phosphorylation of, Bik1p,
affecting its ability to interact with tubulins or micro-
tubules. Alternatively, TOR may regulate the amount of
free Bik1p available to interact with microtubules. In addi-
tion to microtubule-associated Bik1p, we have detected a
substantial amount of Bik1p as punctate structures in the
cytoplasm, closely resembling the distribution of Tor1p
(data not shown). Thus, TOR may regulate the selective
release of Bik1p to designated subcellular locations in
response to intracellular, extracellular or localized cues.
Supplementary material
Supplementary material including figures showing effects of rapamycin
on karyogamy and chromosomal stability, a table showing the yeast
strains used and additional methodological detail is available at
http://current-biology.com/supmat/supmatin.htm.
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